VectraCor, Author at Medgadget Medgadget

VectraCor

VectraCor is a medical device company in Totowa, NJ with a disruptive and patented technology in the cardiovascular market place. Cardiovascular disease is the #1 disease and killer in the US and World. VectraCor’s technology has the potential to be the new standard of care in EKGs and cardiac monitoring.

Author's Posts

Releases - Featured

VectraCor Inc Receives Innovative Technology Contract from Vizient, Inc. for VectraplexECG System with CEB®, Cardiac Electrical Biomarker

June 28th, 2018 VectraCor, Inc. announced its VectraplexECG System with CEB® Cardiac Electrical Biomarker has received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The contract was based on a recommendation of VectraCor’s VectraplexECG System with...

Upcoming conferences

march

20marallday21alldayInternational Conference on Bioinformatics & System Biology 2019Singapore City, Singapore

25marallday26allday4th World Congress and Expo on Pharmaceutics and Drug Delivery Systems, 2019Milan, Italy

25marallday26allday2nd International Summit on Dermatology, 2019Milan, Italy

25marallday27alldayFDA Boot Camp 2019New York, NY, USA

Event Details

10% off with code D10-874-874AX01

This premier event is designed to provide professionals working in the life sciences space with a strong working knowledge of core FDA competencies.

In addition to providing a “101” training, our updated agenda offers advanced guidance sessions discussing the pathways to approval, a patent and IP overview for pharmaceuticals, post-approval issues, and recalls and withdrawals. In addition, each step of the process comes with strategies to apply this knowledge to real-life situations.

Experts at this event will help you:

COMPREHEND the structure of FDA
GAIN a practical working knowledge of clinical trial process for pharmaceutical products
MASTER the basics of the application and approval processes for drugs, as well as follow-on products such as ANDA’s and Biosimilars
RECOGNIZE the pivotal role of labeling, as well as promotions and off-label communications in drugs and biologics
APPRECIATE the complexities of pharmaceutical IP and the regulatory balance between brand name and generic products
UNDERSTAND the importance of cGMPs to the post-approval regulatory process
NAVIGATE the protocols of adverse events monitoring, signal detection, product withdrawals, and recalls

Register by January 18, 2019 for best rates plus save an extra 10% off with code D10-874-874AX01

Time

march 25 (Monday) - 27 (Wednesday)

Location

Park Lane Hotel New York

36 Central Park S, New York, NY 10019

Organizer

American Conference Institute

Learn More

Calendar GoogleCal

25marallday28alldayMEDinISRAEL - the flagship event of the Digital Health industry in IsraelTel Aviv, Israel

26marallday27alldayMedical Imaging Convention - 2019 Birmingham, UK

26marallday27alldayThe European Neuro Convention - 2019Birmingham, UK

26marallday27alldayEuropean Oncology Convention - 2019Birmingham, UK

april

08aprallday09alldayWorld Congress on Neurology & Neurological Disorders 2019Toronto, Canada

08aprallday10allday6th World Congress on Human Genetics and Genetic Diseases, 2019Abu Dhabi, UAE

09aprallday11alldayMedTech Strategist Innovation Summit Dublin 2019Dublin, Ireland

22aprallday23allday2nd Annual Conference on orthopedics and Osteoporosis 2019Barcelona, Spain

24aprallday26allday8th Digital Marketing for Medical Devices WestSan Diego, CA, USA